$SLS
The loudest part of a biotech story is usually the announcement.
The quietest part is often right before it.
Right now all anyone sees is:
π Red candles π΄ Waiting π€¬ Frustration
What they don't see is what may be happening behind the scenes:
π Data review 𧬠Trial preparation π Conference planning π° Press release drafting
Sometimes the calm before the storm feels exactly like boredom.
#SLS
Pretend I'm standing in front of the Sharks pitching $SLS.
"Sharks, I'm asking for a $7.15 valuation.
For that price, you get:
β A Phase 3 cancer immunotherapy trial β 126 AML patients enrolled β 78 events already reported β Final analysis trigger approaching β WT1 platform potential across multiple cancers
And the market currently values all of that at less than the price of two Chipotle burritos per share."
Who's in? π¦
#SLS #Sharktank
$SLS
June 11 = 30 days since the 78th REGAL event update.
A lot of investors expected the 80th event by now.
Instead, we're still waiting.
The longer this goes, the more one question keeps getting louder:
Why?
#SLS#Biotech